Serum Institute To Produce Oxford Ebola Vaccine With CEPI Backing
The Serum Institute of India (SII) will manufacture clinical trial doses of an experimental Ebola vaccine developed by the University of Oxford after receiving new financial support from the Coalition for Epidemic Preparedness Innovations (CEPI). The funding aims to accelerate vaccine development against the deadly Bundibugyo strain of the Ebola virus. CEPI announced an investment…